K
Kiora Pharmaceuticals, Inc. (KPRX)
NCM – Real vaqt narxi. Valyuta: USD
2.54
-0.01 (-0.39%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.54
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
2.54
-0.01 (-0.39%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.54
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
Kiora Pharmaceuticals, Inc., klinik tadqiqot bosqichidagi ixtisoslashtirilgan farmatsevtika kompaniyasi, oftalmik kasalliklarni davolash uchun terapiyani ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Uning asosiy mahsuloti KIO-301 bo'lib, ko'rishni tiklashga qodir kichik molekula bo'lib, u retinit pigmentosa, xoroideremiya va Stargardt kasalligini davolash uchun 2-faza klinik sinovlarida. Kompaniya, shuningdek, KIO-104ni ishlab chiqmoqda, bu dihidroorotat dehidrogenaza ingibitori bo'lgan steroid bo'lmagan, immunomodulyatsion, kichik molekula bo'lib, u orqa infeksiyasiz uveitni davolash uchun 1b/2a faza tadqiqotida, shuningdek, proliferativ vitreoretinopatiyani davolash uchun preklinik rivojlanishda; va KIO-101, revmatoid artritning ko'z ko'rinishini davolash uchun tomchi preparat. Kompaniya KIO-301ni ishlab chiqish bo'yicha Théa Open Innovation bilan strategik rivojlanish va tijoratlashtirish shartnomasiga ega. Kompaniya Qo'shma Shtatlar, Avstriya va Avstraliyada faoliyat yuritadi. Kompaniya ilgari Eyegate Pharmaceuticals, Inc. nomi bilan tanilgan va 2021 yil noyabr oyida Kiora Pharmaceuticals, Inc. nomiga o'zgargan. Kiora Pharmaceuticals, Inc. 1998 yilda tashkil etilgan va shtab-kvartirasi Kaliforniyaning Encinitas shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Brian M. Strem Ph.D. | President, CEO & Director |
| Dr. Stefan Sperl Ph.D. | Executive Vice President of CMC & Operations |
| Ms. Melissa Tosca CPA | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-18 | 8-K | kprx-20260618.htm |
| 2026-06-11 | 8-K | kprx-20260610.htm |
| 2026-05-18 | S-3 | s-3xapril2026.htm |
| 2026-05-08 | 8-K | kprx-20260508.htm |
| 2026-05-01 | ARS | a10k-20251231xkprx.pdf |
| 2026-04-30 | DEF 14A | kprx-20260430.htm |
| 2026-04-21 | D | |
| 2026-04-07 | 8-K | kprx-20260403.htm |
| 2026-04-02 | 8-K | kprx-20260401.htm |
| 2026-03-25 | S-8 | kiorapharmaceuticalsinc-sx.htm |